Asymmetric Synthesis of (-)-fosfomycin and its Trans- (1S,2S)-diastereomer Using a Biocatalytic Reduction as the Key Step

Christian P. Marocco, Erik V. Davis, Julie E. Finnell, Phung-Hoang Nguyen, Scott C. Mateer, Ion Ghiviriga, Clifford W. Padgett, Brent D. Feske

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Fosfomycin is a gram positive and gram negative antibiotic that contains an asymmetric epoxide. An enzyme library was screened for its ability to reduce dimethyl(1-chloro-2-oxopropyl)phosphonate to the corresponding asymmetric chlorohydrin. Homology models were built in MOE, which were shown to accurately model the enzyme-substrate complex displaying the stereoselectivity that we observed. Two enzymes, YDR368w and YHR104w, were chosen for the scale up and synthesis of fosfomycin and its trans-(1S,2S)-diastereomer.

Original languageAmerican English
JournalTetrahedron Asymmetry
Volume22
DOIs
StatePublished - Jan 1 2011

Keywords

  • Asymmetric synthesis
  • Ensyme
  • Gram positive
  • Gram-negative bacteria
  • Homology modeling
  • Organic chemistry
  • Scaling up

DC Disciplines

  • Chemistry

Fingerprint

Dive into the research topics of 'Asymmetric Synthesis of (-)-fosfomycin and its Trans- (1S,2S)-diastereomer Using a Biocatalytic Reduction as the Key Step'. Together they form a unique fingerprint.

Cite this